Ariez B.V.
Podcasts for the professional healthcare people
Ariez B.V.
Prof. dr. Bob Li
•
Ariez Publishing
Prof. dr. Michael Boyer shares the results of the phase II CodeBreak 100 trial and discusses what these results mean for patients with non-small cell lung cancer harbouring G12C KRAS mutations